• Get involved in our studies!

  • Home
  • About Us
  • Current Studies
    • Cancer Studies
      • Inflammation-Induced CNS Glutamate During Breast Cancer Treatment
      • Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors with High Inflammation
      • Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy
      • Predicting Risk for Post-traumatic Stress Disorder in African American Women with Breast Cancer
    • Depression Studies
      • Inflammation-Induced CNS Glutamate Changes in Depression
      • Inflammation-Related Alterations in Neurociruitry: Reversal with Levodopa
      • Magnetic Resonance Spectroscopy (MRS) in Midlife Depression
      • Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression
      • Effects of Bupropion versus Escitalopram on Reward Circuitry and Motivational Deficits in Patients with Major Depression and Increased Inflammation and Anhedonia
    • Schizophrenia Studies
      • Impact of Inflammation on Reward Circuits, Motivational Deficits, and Negative Symptoms in Schizophrenia
  • People
  • Publications
  • Contact Us
  • In the News

In the News

In The News

The Need for Speed

New evidence from Dr. Goldsmith’s lab suggests that individuals with schizophrenia or schizoaffective disorder have slower outcomes on psychomotor tasks. Read more at Psychiatric Times.

By , 7 months7 months ago
In The News

High Levels of Inflammation and Blood Glucose May Contribute to Anhedonia in MDD

A new paper from our group examines the combined presence of high blood glucose and low tyrosine metabolism in people with Major Depressive Disorder.

By , 8 months8 months ago
In The News

Can anti-inflammatory strategies light up the dim depression pipeline?

Several institutions and organizations including our own are advancing the research of anti-inflammatory drugs as treatment methods for depression and depressive symptoms. Read about it at Nature.

By , 10 months10 months ago
In The News

Microglia: a new target in the brain for depression, Alzheimer’s, and more?

Neuroinflammation is rapidly being tied to a number of physical and cognitive health issues, presenting a new direction for potential treatments.

By , 1 year10 months ago
In The News

Inflammation is Aging your Brain

Dr. Miller spoke with Dave Asprey on his Podcast, Bulletproof radio, to discuss inflammation’s effects on aging. Listen to it here.

By , 1 year10 months ago
In The News

Science Says This Is How Stress Kills Your Motivation

How can you maintain your motivation during stressful times? Our research provides one answer. See more at Inc.

By , 2 years10 months ago
In The News

Does Chronic Inflammation Reduce Motivation?

Christopher Bergland takes a look at our research on inflammation and motivation at Psychology Today.

By , 2 years10 months ago
In The News

How Chronic Inflammation May Drive Down Dopamine and Motivation

Computational modeling provides a new look at chronic, low grade inflammation’s effects on motivation. Read more at Medical Express.

By , 2 years10 months ago
In The News

Next-Generation Antidepressants Show Promise for Treatment-Resistant Disease

Inflammation research at Emory helps develop our understanding of treatment-resistant depression. Dr. Miller discusses this research with Healio.

By , 2 years10 months ago
In The News

Can My Dentist Cure Depression?

Dr. Sarah Gingell analyzes an unexpected question with the help of our recent findings. Read about it in Psychology Today.

By , 2 years10 months ago

Posts navigation

1 2 … 4 Next
Emory University Behavioral Immunology Program

Address
Emory University Clinic B
1365 Clifton Road NE
Suite B5101
Atlanta, GA 30322

Phone
404-727-8229


Hestia | Developed by ThemeIsle